Brief: Genera Biosystems
Genera Biosystems (GBI) says the Australian Therapeutic Goods Administration has approved the entry of the company’s PapType Human Papillomavirus test kit onto the Australian Register of Therapeutic Goods.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles